| Literature DB >> 32283845 |
Svetlana V Malysheva1, Patrick P J Mulder2, Julien Masquelier1.
Abstract
Cardiac glycosides (CGs) are naturally occurring plant secondary metabolites that can be toxic to humans and animals. The aim of this work was to develop a targeted analytical method utilizing liquid chromatography-tandem mass spectrometry (LC-MS/MS) for quantification of these plant toxins in a herbal-based food and human urine. The method included oleandrin, digoxin, digitoxin, convallatoxin, and ouabain. Samples of culinary herbs were extracted with acetonitrile and cleaned using Oasis® MAX solid-phase extraction (SPE), while samples of urine were diluted with acidified water and purified on Oasis® HLB SPE cartridges. Limits of quantification were in the range of 1.5-15 ng/g for herbs and 0.025-1 ng/mL for urine. The mean recovery of the method complied with the acceptable range of 70-120% for most CGs, and relative standard deviations were at maximum 14% and 19% for repeatability and reproducibility, respectively. Method linearity was good with calculated R² values above 0.997. The expanded measurement uncertainty was estimated to be in the range of 7-37%. The LC-MS/MS method was used to examine 65 samples of culinary herbs and herb and spice mixtures collected in Belgium, from supermarkets and local stores. The samples were found to be free from the analyzed CGs.Entities:
Keywords: LC-MS/MS; herbs; oleandrin; plant toxins; urine; validation
Mesh:
Substances:
Year: 2020 PMID: 32283845 PMCID: PMC7232191 DOI: 10.3390/toxins12040243
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1Chemical structures of the target cardiac glycosides.
Figure 2Full ESI(+)-MS spectra obtained through the flow injection analysis of a 1 µg/mL solution of convallatoxin (CON) in H2O + 10 mM HCOONH4 (pH 3):acetonitrile (ACN) (50:50, v/v) (a) and H2O + 10 mM NH4HCO3 (pH 9):ACN (50:50, v/v) (b) and ESI(+)-MS/MS spectrum in H2O + 10 mM NH4HCO3 (pH 9):ACN (50:50, v/v) (c). The vertical axes represent relative peak intensity (normalized to 100%), while the horizontal axes display measured m/z (mass-to-charge ratio) values. The MS setup is given in Section 5.3.
Electrospray ionization positive (ESI)(+)-MS/MS parameters for detection of cardiac glycosides.
| Analyte | Precursor Ion ( | Cone Voltage (V) | Product Ions ( | Collision Energy (eV) |
|---|---|---|---|---|
| Oleandrin | 577.2 [M + H]+ | 30 | 15 | |
| Digoxin | 781.2 [M + H]+ | 25 | 10 | |
| Digitoxin | 782.4 [M + NH4]+ | 30 | 10 | |
| Convallatoxin | 551.1 [M + H]+ | 20 | 10 | |
| Ouabain | 585.1 [M + H]+ | 30 | 15 | |
| Digoxin-d3 2 | 784.2 [M + H]+ | 25 | 10 |
1 Highlighted in bold: Most abundant product ion, 2 internal standard.
Figure 3LC-MS/MS selected reaction monitoring (SRM) chromatograms of a single injection of a standard mixture of DIGI (a), DIGO (c), CON (d), and ouabain (OUB) (e) at a concentration of 2.5 ng/mL and OLE (b) at a concentration of 0.25 ng/mL, dissolved in H2O:ACN (80:20, v/v). For each cardiac glycoside (CG) the most abundant SRM transition is displayed. The vertical axes represent relative peak intensity (normalized to 100%), while the horizontal axes display retention time (in min). The chromatographic conditions applied are given in Section 5.2.
Validation data for cardiac glycosides in culinary herbs.
| Analyte | Reporting Limit (ng/g) | Linear Range (ng/g) | R2 | Concentration Level | Recovery ± SD1 | Repeatability (RSDr) (%) | Reproducibility (RSDwR) (%) | Measurement Uncertainty |
|---|---|---|---|---|---|---|---|---|
| (ng/g) | (%) | (%) | ||||||
| Oleandrin | 2.5 | 2.5–200 | 0.9993 | 5 | 82 ± 7 | 7 | 8 | 17 |
| 25 | 86 ± 6 | 6 | 7 | 14 | ||||
| 100 | 80 ± 6 | 6 | 7 | 15 | ||||
| Mean: 83 ± 6 | Mean: 6 | Mean: 8 | ||||||
| Digoxin | 10 | 10–400 | 0.9995 | 10 | 121 ± 11 | 11 | 11 | 21 |
| 50 | 114 ± 7 | 7 | 7 | 13 | ||||
| 200 | 111 ± 10 | 6 | 10 | 19 | ||||
| Mean: 115 ± 10 | Mean: 9 | Mean: 9 | ||||||
| Digitoxin | 20 | 20–400 | 0.9995 | 20 | 86 ± 10 | 14 | 14 | 27 |
| 100 | 96 ± 11 | 9 | 12 | 24 | ||||
| 400 | 95 ± 13 | 7 | 15 | 31 | ||||
| Mean: 92 ± 12 | Mean: 10 | Mean: 14 | ||||||
| Convallatoxin | 10 | 10–400 | 0.9994 | 10 | 52 ± 7 | 7 | 14 | 28 |
| 50 | 55 ± 9 | 12 | 17 | 34 | ||||
| 200 | 57 ± 7 | 10 | 12 | 25 | ||||
| Mean: 55 ± 7 | Mean: 9 | Mean: 14 |
1 SD: Standard deviation.
Validation data for cardiac glycosides in human urine.
| Analyte | Reporting Limit (ng/mL) | Linear Range (ng/mL) | R2 | Concentration Level | Recovery ± SD1 | Repeatability (RSDr) (%) | Reproducibility (RSDwR) (%) | Measurement Uncertainty |
|---|---|---|---|---|---|---|---|---|
| (ng/mL) | (%) | (%) | ||||||
| Oleandrin | 0.1 | 0.1–20 | 0.9987 | 0.5 | 80 ± 13 | 3 | 18 | 36 |
| 2.5 | 84 ± 9 | 3 | 13 | 26 | ||||
| 10 | 87 ± 5 | 2 | 7 | 13 | ||||
| Mean: 84 ± 10 | Mean: 3 | Mean: 13 | ||||||
| Digoxin | 1 | 1–200 | 0.9993 | 5 | 93 ± 10 | 4 | 12 | 24 |
| 25 | 92 ± 6 | 2 | 7 | 14 | ||||
| 100 | 92 ± 4 | 3 | 5 | 9 | ||||
| Mean: 92 ± 7 | Mean: 3 | Mean: 8 | ||||||
| Digitoxin | 1 | 1–200 | 0.9975 | 5 | 86 ± 14 | 7 | 19 | 37 |
| 25 | 95 ± 10 | 6 | 12 | 24 | ||||
| 100 | 88 ± 5 | 3 | 5 | 11 | ||||
| Mean: 89 ± 11 | Mean: 5 | Mean: 12 | ||||||
| Convallatoxin | 1 | 1–200 | 0.9993 | 5 | 91 ± 15 | 4 | 19 | 36 |
| 25 | 94 ± 7 | 2 | 8 | 26 | ||||
| 100 | 96 ± 3 | 1 | 3 | 16 | ||||
| Mean: 94 ± 9 | Mean: 3 | Mean: 10 | ||||||
| Ouabain | 1 | 1–200 | 0.9994 | 5 | 87 ± 14 | 4 | 18 | 37 |
| 25 | 89 ± 11 | 6 | 13 | 17 | ||||
| 100 | 93 ± 7 | 4 | 8 | 7 | ||||
| Mean: 90 ± 11 | Mean: 5 | Mean: 13 |
1 SD: Standard deviation.